We are live on ! Find out more
MURA

Mural Oncology
MURA

Delisted

MURA was delisted on the 4th of December, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in Mural Oncology in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

30.72% less ownership

Funds ownership: 30.72% → 0% (-31%)

100% less funds holding

Funds holding: 61 → 0 (-61)

100% less capital invested

Capital invested by funds: $11M → $0 (-$11M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 61

Holders
–
Holders Change
-61
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
61
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$1.22M
2
NM
Newtyn Management
New York
-$1.08M
3
OAC
OMERS Administration Corp
Ontario, Canada
-$1.06M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$941K
5
RC
Rangeley Capital
Connecticut
-$631K
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
– -$1.22M -588,800 Closed
NM
2
Newtyn Management
New York
– -$1.08M -522,919 Closed
OAC
3
OMERS Administration Corp
Ontario, Canada
– -$1.06M -511,000 Closed
Vanguard Group
4
Vanguard Group
Pennsylvania
– -$941K -454,712 Closed
RC
5
Rangeley Capital
Connecticut
– -$631K -305,000 Closed
BlackRock
6
BlackRock
New York
– -$595K -287,580 Closed
RC
7
RBF Capital
California
– -$588K -283,912 Closed
Millennium Management
8
Millennium Management
New York
– -$535K -258,487 Closed
Citadel Advisors
9
Citadel Advisors
Florida
– -$535K -258,250 Closed
DAM
10
Deltec Asset Management
New York
– -$371K -179,057 Closed
Geode Capital Management
11
Geode Capital Management
Massachusetts
– -$363K -175,111 Closed
TC
12
Torno Capital
Massachusetts
– -$352K -170,000 Closed
YCM
13
Yakira Capital Management
Connecticut
– -$339K -163,954 Closed
FIA
14
FNY Investment Advisers
New York
– -$304K -147,076 Closed
Renaissance Technologies
15
Renaissance Technologies
New York
– -$302K -146,000 Closed
Morgan Stanley
16
Morgan Stanley
New York
– -$211K -102,173 Closed
Primecap Management
17
Primecap Management
California
– -$192K -92,800 Closed
Simplex Trading
18
Simplex Trading
Illinois
– -$186K -90,256 Closed
State Street
19
State Street
Massachusetts
– -$176K -84,873 Closed
PCM
20
PenderFund Capital Management
British Columbia, Canada
– -$171K -82,800 Closed
BCM
21
BML Capital Management
Indiana
– -$119K -57,500 Closed
VF
22
Virtu Financial
New York
– -$115K -55,721 Closed
SC
23
Shay Capital
New York
– -$93.3K -45,088 Closed
Jane Street
24
Jane Street
New York
– -$84.1K -40,609 Closed
Dimensional Fund Advisors
25
Dimensional Fund Advisors
Texas
– -$82.4K -39,822 Closed
1
2 3

MURA Hedge Fund Activity: Q4 2025 in Review

0 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q4 2025, worth a combined $0 — down 100% from $11M a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of MURA and 0 opened new positions — a net loss of 61 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was OrbiMed, exiting entirely with an estimated $1.22M sold.

  • 0 institutional investors held Mural Oncology (MURA) as of Q4 2025, down from 61 in Q3 2025.
  • Funds reported $0 of Mural Oncology stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Mural Oncology positions in Q4 2025 and 61 closed out, a net change of -61 holders.
  • The largest Mural Oncology seller in Q4 2025 was OrbiMed, an estimated $1.22M sold.

Based on aggregated 13F filings for Q4 2025.